ZFP36 and prostate cancer: This study presented clinical and biochemical evidence, suggesting that alterations in zinc metabolism may be of vital importance in PCa pathogenesis, and timely zinc supplementation may improve ZFP36 expression levels, thereby inhibiting prostate cancer development, which needs to be further confirmed in follow-up studies.